Study on preoperative concurrent chemoradiotherapy with S-1 in oral cancer (Phase II study)
Phase 2
- Conditions
- Oral cancer
- Registration Number
- JPRN-UMIN000002329
- Lead Sponsor
- Oral and Maxillofacial Surgery, Graduate School, Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
The cases who have simultaneously another cancer, the cases who have severe complication in their body
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor reduction 4 weeks after chemoradiotherapy
- Secondary Outcome Measures
Name Time Method Adverse events on chemoradiotherapy